KUREHA CORPORATION

KUREHA CORPORATION

KC
Company Profile

KUREHA CORPORATION

Tokyo, Japan

News Release FAQ/Contact 日本語 中文 About KUREHA About KUREHA TOP History Kureha’s Challenge
0Products
0People
0Events
0Locations

Overview

Company details and contact information.

About

About KUREHA CORPORATION Visit Kureha to explore a Japanese-engineered bioabsorbable surgical adhesion barrier film designed for controlled healing and surgeon-friendly handling. Leveraging polymer engineering expertise in polyglycolic acid (PGA), specialty polymers, and advanced formulation technologies, Kureha is developing a film with tuned swelling and degradation to maintain barrier function throughout the critical healing window. The flexible film supports easy placement and repositioning, achieves reliable tack after a short setting time, using components with extensive surgical use to aid OR adoption and evaluation. Manufacturing is planned at two sites in Japan and the United States, with OEM collaboration beginning pre‑approval or at commercial scale‑up to ensure smooth transfer and launch readiness.*The adhesion barrier film is under development and not cleared or approved by the FDA; described features reflect design intent and development objectives. Meet us at MD&M West to see samples firsthand and discuss potential engagement and OEM collaboration. Visit Kureha to explore a Japanese-engineered bioabsorbable surgical adhesion barrier film designed for controlled healing and surgeon-friendly handling. Leveraging polymer engineering expertise in polyglycolic acid (PGA), specialty polymers, and advanced formulation technologies, Kureha is developing a film with tuned swelling and degradation to maintain barrier function throughout the critical healing window. The flexible film supports easy placement and repositioning, achieves reliable tack after a short setting time, using components with extensive surgical use to aid OR adoption and evaluation. Manufacturing is planned at two sites in Japan and the United States, with OEM collaboration beginning pre‑approval or at commercial scale‑up to ensure smooth transfer and launch readiness.*The adhesion barrier film is under development and not cleared or approved by the FDA; described features reflect design intent and development objectives. Meet us at MD&M West to see samples firsthand and discuss potential engagement and OEM collaboration.

Address
3-3-2, Nihonbashi-Hamacho, Chuo-ku,, Tokyo 103-8552, Japan